Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy

Archives of Neurology

Volumn 54, Issue 9, 1997, Pages 1104-1108

  Ghika, Joseph ^a   Bogousslavsky, Julien ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN STEM; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

EID: 0030827845     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550210038010     Document Type: Article

References (45)

1. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia, and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia, and dementia. Arch Neural. 1964:10:333-359.
2. Litvan I, Agid Y, Jankovic J, Goetz C, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (SRO syndrome). Neurology. 1996; 46:922-923.
3. Golbe LI, Davis PH. Progressive Supranuclear Palsy. Baltimore, Md: Williams & Wilkins;1993.
4. Tolosa E, Valldeoriola F, Marti Mj. Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neural Transm Basic Neurosci Neurol Sect Psychiatry Sect. 1994;42(suppl): 15-31.
5. Collins SJ, Ahlskog JE, Paris! JE, Maranganore DM. Progressive supranuclear palsy: neuropathological based diagnostic criteria. J Neurol Neurosurg Psychiatry. 1995;58:167-173.
6. Duvoisin RC. Clinical diagnosis. In: Litvan I, Agid Y, eds. Progressive Supranuclear Palsy: Clinical and Research Approaches. New York, NY: Oxford University Press Inc; 1992:15-33.
7. Mäher ER, Lees AJ. The clinical features and natural history of the SteeleRichardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1986;36:1005-1008.
8. Hauw JJ, David SE, Dickson D, et al. Preliminary WINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). -, Neurology. 1994:44:2015-2019.
9. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neumpathol Exp Neurol. 1996:55:97-105.
10. Bugiani L, Mancardi GL, Brusa A, Edeli E. The fine structure of subcortical neu-rofibrillary tangles in progressive supranuclear palsy Acts Neuropathol (Berl). 1979;45:147-152.
11. Tellez-Nagel I, Wisniewski HM. Ultrastructure of neurotibrillary tangles in SteeleRichardson-OIszewski syndrome. Arch Neural. 1973:29:324-327.
12. Ruberg M, Hirsch E, Javoy-Agid F. Neurochemistry. In: Litvan I, Agid Y, eds. Progressive Supranuclear Palsy: Clinical'and Researchjtyprracftes. New York, NY: Oxford University Press Inc; 1992:89-109.
13. Newman GC. Treatment of progressive supranuclear palsy with tricyclic antidepressants. Neurology. 1985:35:1189-1193.
14. Ghika JA, Tennis M, Huffman E, Schoenfield D, Growdon JH. Idazoxan treatment in progressive supranuclear palsy. Neurology. 1991;41:986-991.
15. Pascual J, Berciano J, Gonzales AM, Grijalba B, Figols J, Pazos A. Autoradiographie demonstration of loss of alpha-2-adrenoreceptors in progressive supranuclear palsy. J Neurol Sei. 1993;114:165-169.
16. Malessa S, Hirsch EC, Cervera P, Duyckaerts C, Agid Y. Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration. Neurology. 1990;40:1739-1743.
17. Growdon JH, Ghika J, Tennis M, Cole DG, Schonfield D. Noradrenergic mechanisms in progressive supranuclear palsy. In: Narabayashi H, Mizuno Y, eds. Norepinephrine Deficiency and Its Treatment With L-threo-DOPS in Parkinson 's Disease and Related Disorders. Pearl River, NY: Parthenon Publishing Group Inc; 1993:117-131.
18. Zubenko GS, Volicer L, Direnfld LK, Freeman M, Langlais PJ, Nixon RA. Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy. Brain Res. 1985:328: 215-221.
19. Dubinsky RM, Jankovic J. Progressive supranuclear palsy and multi-infarct state. Neurology. 1987;37:570-576.
20. CAPIT Committee. Core assessment program for intracerebral transplantations (CAPIT). MovDisord. 1992;7:2-13.
21. Quinn N, Critchley P, Marsden CD. Young-onset Parkinson's disease. MovDisord. 1987;2:73-91.
22. Quinn N. Multiple system atrophy. In: Marsden CD, Fahn S, eds. Movement Disorders 3. Newton, Mass: Butterworth-Heinemann; 1994:265-268.
23. Wenning GK, Ben Shlomo Y, Malglaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain. 1994;117:835-845.
24. Staal A, Vianney de Jong JMB. Non-familial olivopontocerebellar atrophy. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of Clinical Neurology. Amsterdam, the Netherlands: Elsevier Science Publishers: 1991:519-536.
25. Eadie MJ. Olivo-ponto-cerebellar atrophy (Déjerine-Thomas type 9). In: Vinken PJ, Bruyn GW, Klawasn HL, eds. Handbook of Clinical Neurology. Amsterdam, the Netherlands: Elsevier Science Publishers; 1991:511-518.
26. Watts RL, Mirra SS, Richardson EP Jr. Corticobasal ganglionic degeneration. In: Marsden CD, Fahn S, eds. Movement Disorders 3. Newton, Mass: ButterworthHeinemann; 1994:3:286-287.
27. Quinn NP. Dementia and Parkinson's disease. In: Wolters CH, Scheltens P, eds. Mental Dysfunction in Parkinson's Disease. Dordrecht, the Netherlands: ICG Publications; 1994:113-121.
28. McKeith IG, Galasko D, Kosaka K, et al. Guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB). Neurology. 1996:47:11131124.
29. Critchley M. Arteriosderotic parkinsonism. Brain. 1929:52:23-83.
30. Parkes JD, Marsden CD, Rees JE, et al. Parkinson's disease, cerebral arteriosclerosis and senile dementia: clinical features and response to levodopa. QJMed. 1974:93:49-61.
31. Tolosa ES, Santamaria J. Parkinsonism and basal ganglia infarcts. Neurology. 1984:34:1516-1518.
32. Rickenbach M, Wietlisbach V, Beretta-Piccoli C, Mocetti T, Gutzwiler F. Tabakkonsum, Blutdruck und Körpergewicht in der schweizer Bevölkerung: MONICAStudie, 1988-89. SchweizMed Wochenschr. 1993;123(suppl 48):21-28.
33. Schainker BA. Autopsy diagnosis of progressive supranuclear palsy mistaken clinically for stroke: case report. Mo Med. 1978:75:227-229.
34. Winikater J, Jankovic J. Vascular progressive supranuclear palsy. J Neural Transm Basic Neurosci Neurol Sect Psychiatry Sect. 1994;42(suppl):189-201.
35. Foster NL, Gilman S, Berent S, et al. Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities. J Neurol Neurosurg. 1992:55:707-713.
36. Will RG, Lees AJ, Gibb W, Barnard RO. A case of progressive subcortical gliosis diagnosed clinically as Steele-Richardson-Olszewski syndrome. J Neurol Neurosurg Psychiatry. 1988:51:1224-1227.
37. Jankovic J. Progressive supranuclear palsy: paraneoplastic effects of bronchial carcinoma. Neurology. 1985:35:44-46.
38. de Bruin VMS, Lees AJ, Daniel SE. Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report. Mov Disord. 1992:7:335-338.
39. Fearnley JM, Revesz T, Brooks DJ, Frackowiack RSJ, Lees AJ. Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry. 1991:54:159-161.
40. Kobayashi M, lijima M, Hatano M, Akai K, Yoshikawa N. An autopsy case of progressive supranuclear palsy with Lafora-like intraneuronal inclusions. AdvtJeurolSci. 1975:19:384-395.
41. Marttila RT, Rinne UK. Arteriosclerosis, heredity, and some previous infections in the etiology of Parkinson's disease: a case-control study. Clin Neurol Neurosurg. 1976:79:46-56.
42. Kessler II. Epidemiologie studies of Parkinson's disease, III: a communitybased survey. Am JEpidemiol. 1972;96:242-254.
43. Hankey GJ, Stewart-Wynne EG. Bilateral intracerebral hemorrhage presenting with supranuclear ophthalmoplegia, bradykinesia and rigidity. Clin Exp Neurol. 1987:23:195-199.
44. Huang C, Woo E, Yu YL, Chan FL Lacunar syndromes due to brainstem infarct and hemorrhage. J Neurol Neurosurg Psychiatry. 1988:51:509-515.
45. Ghika J, Bogousslavsky J. Abnormal movements. In: Bogousslavsky J, Caplan LR, eds. Stroke Syndromes. New York, NY: Cambridge University Press; 1995: 90-93.